The Effect of Color Therapy on Depression, Stress, Anxiety and Quality of Life in Hemodialysis Patients: A Randomized Controlled Study (Color Therapy)

This study was conducted to examine the effect of color therapy on depression, stress, anxiety and quality of life in hemodialysis patients.

Study Overview

• Status: Completed
• Conditions: Hemodialysis; Color Therapy
• Intervention / Treatment: Other: Color therapy

Detailed Description

Many patients on hemodialysis treatment require hemodialysis, which requires hospitalization three times a week for four hours each dialysis session. Therefore, practices such as color therapy may be useful in the management of psychological symptoms in these patients.

• Study Type: Interventional
• Enrollment (Actual): 60
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Turkey
  • Merkez
    • Elazığ, Merkez, Turkey, 23119
      • Fırat university

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult; Older Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• Be on hemodialysis treatment for at least 6 months,
• No sleeping pills or sedative medication,
• No physical or cognitive impairment that prevents them from understanding the education and no diagnosis of a psychiatric illness,
• The patient or someone living in the same household with the patient is literate,
• Patients have no vision problems,
• Patients must be 18 years of age or older.

Exclusion Criteria:

• Being on hemodialysis treatment for less than 6 months,
• Taking sleeping pills or sedative medication,
• Being diagnosed with a physical illness or cognitive impairment or psychiatric illness that prevents understanding the education provided,
• Illiteracy of the patient and relatives,
• Patients have vision problems,
• Refusing to participate in the research,
• Under 18 years of age

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Supportive Care
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Color therapy group; group doing color therapy	Other: Color therapy; In the experimental group, color therapy was applied 3 days a week for the first two weeks, while no intervention was performed in the third and fourth weeks. In the fifth and seventh weeks, color therapy was applied for 15 minutes each day, while no intervention was performed in the sixth week.
No Intervention: No color therapy group; group not doing color therapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Depression Anxiety Stress-21 scale (DASS-21)	The 21-question DASS scale used in the study was taken by Henry and Crawford. This scale (DASS-21) has 7 questions each to measure the dimensions of depression, stress and anxiety. The scale is a 4-point Likert-type scale, coded as 0 "not applicable to me", 1 "somewhat applicable to me", 2 "generally applicable to me", and 3 "completely applicable to me".	8 week
Short Form-12 (SF-12) Quality of Life Scale	Ware et al. decided to develop a more practical form of the SF-36 that could be administered in a shorter time and developed the SF-12, which contains the same sub-dimensions as the SF-36 by reducing the number of questions. In addition to the fact that the SF-12 was created in such a way that the same component summary scores can be obtained as the SF-36, the fact that it contains fewer items and therefore has a shorter administration time provides a great advantage. Although it has been demonstrated that the SF-36 scale has sufficient validity and reliability in studies conducted in both patient and normal sample groups in our country, the validity and reliability study of the Turkish form of the SF-12, which was developed as a shorter alternative to the SF-36, was attempted. Similar to SF-36, SF-12 consists of 8 sub-dimensions and 12 items including physical functioning (2 items), physical role (2 items), body pain (1 item), general health (1 item), energy (1 item), social function	8 week

Collaborators and Investigators

• Sponsor: Erzincan Binali Yildirim Universitesi
• Investigators: Principal Investigator: Gülcan Bahçecioğlu Turan, Associate Professor, Firat University; Study Director: Zülfünaz Özer, Associate Professor, Istanbul Sebahattin Zaim University; Study Director: Safiye Yanmış, Assistant Professor, Erzincan Binali Yildirim Universitesi; Study Director: Mukadder Mollaoğlu, Professor Doctor, Cumhuriyet University

Study record dates

Study Major Dates

• Study Start (Actual): April 1, 2024
• Primary Completion (Actual): December 1, 2024
• Study Completion (Actual): February 1, 2025

Study Registration Dates

• First Submitted: March 11, 2025
• First Submitted That Met QC Criteria: March 11, 2025
• First Posted (Actual): March 25, 2025

Study Record Updates

• Last Update Posted (Actual): March 25, 2025
• Last Update Submitted That Met QC Criteria: March 11, 2025
• Last Verified: March 1, 2025

More Information

Terms related to this study

• Keywords: Depression; Quality of Life; Anxiety; Stress; Nursing; Hemodialysis; Color Therapy
• Additional Relevant MeSH Terms: Behavioral Symptoms; Depression
• Other Study ID Numbers: Erzi̇ncanBinaliYildirimUni; Scientific Research Projects (Other Identifier: Istanbul Aydin University Scientific Research Projects)

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO
• IPD Plan Description: After the article is published

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No